Literature DB >> 16227617

Muscle-specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism.

Young-Bum Kim1, Odile D Peroni, William G Aschenbach, Yasuhiko Minokoshi, Ko Kotani, Ariel Zisman, C Ronald Kahn, Laurie J Goodyear, Barbara B Kahn.   

Abstract

Mice with muscle-specific knockout of the Glut4 glucose transporter (muscle-G4KO) are insulin resistant and mildly diabetic. Here we show that despite markedly reduced glucose transport in muscle, muscle glycogen content in the fasted state is increased. We sought to determine the mechanism(s). Basal glycogen synthase activity is increased by 34% and glycogen phosphorylase activity is decreased by 17% (P < 0.05) in muscle of muscle-G4KO mice. Contraction-induced glycogen breakdown is normal. The increased glycogen synthase activity occurs in spite of decreased signaling through the insulin receptor substrate 1 (IRS-1)-phosphoinositide (PI) 3-kinase-Akt pathway and increased glycogen synthase kinase 3beta (GSK3beta) activity in the basal state. Hexokinase II is increased, leading to an approximately twofold increase in glucose-6-phosphate levels. In addition, the levels of two scaffolding proteins that are glycogen-targeting subunits of protein phosphatase 1 (PP1), the muscle-specific regulatory subunit (RGL) and the protein targeting to glycogen (PTG), are strikingly increased by 3.2- to 4.2-fold in muscle of muscle-G4KO mice compared to wild-type mice. The catalytic activity of PP1, which dephosphorylates and activates glycogen synthase, is also increased. This dominates over the GSK3 effects, since glycogen synthase phosphorylation on the GSK3-regulated site is decreased. Thus, the markedly reduced glucose transport in muscle results in increased glycogen synthase activity due to increased hexokinase II, glucose-6-phosphate, and RGL and PTG levels and enhanced PP1 activity. This, combined with decreased glycogen phosphorylase activity, results in increased glycogen content in muscle in the fasted state when glucose transport is reduced.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227617      PMCID: PMC1265843          DOI: 10.1128/MCB.25.21.9713-9723.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

1.  The muscle-specific protein phosphatase PP1G/R(GL)(G(M))is essential for activation of glycogen synthase by exercise.

Authors:  W G Aschenbach; Y Suzuki; K Breeden; C Prats; M F Hirshman; S D Dufresne; K Sakamoto; P G Vilardo; M Steele; J H Kim; S L Jing; L J Goodyear; A A DePaoli-Roach
Journal:  J Biol Chem       Date:  2001-08-24       Impact factor: 5.157

2.  Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle.

Authors:  Jørgen F P Wojtaszewski; Sebastian B Jørgensen; Ylva Hellsten; D Grahame Hardie; Erik A Richter
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

3.  Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model.

Authors:  Katherine V Williams; Alessandra Bertoldo; Bruno Mattioni; Julie C Price; Claudio Cobelli; David E Kelley
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

4.  The content of glycogen phosphorylase and glycogen in preparations of sarcoplasmic reticulum-glycogenolytic complex is enhanced in diabetic rat skeletal muscle.

Authors:  E Garduño; M Nogues; J M Merino; C Gutiérrez-Merino; F Henao
Journal:  Diabetologia       Date:  2001-10       Impact factor: 10.122

5.  A2B receptor activation promotes glycogen synthesis in astrocytes through modulation of gene expression.

Authors:  Igor Allaman; Sylvain Lengacher; Pierre J Magistretti; Luc Pellerin
Journal:  Am J Physiol Cell Physiol       Date:  2002-11-06       Impact factor: 4.249

6.  Disruption of the striated muscle glycogen targeting subunit PPP1R3A of protein phosphatase 1 leads to increased weight gain, fat deposition, and development of insulin resistance.

Authors:  Mirela Delibegovic; Christopher G Armstrong; Lorraine Dobbie; Peter W Watt; Andrew J H Smith; Patricia T W Cohen
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

Review 7.  Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus.

Authors:  Kitt F Petersen; Gerald I Shulman
Journal:  Am J Cardiol       Date:  2002-09-05       Impact factor: 2.778

8.  Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda /zeta but not on glycogen synthase kinase-3.

Authors:  Young-Bum Kim; Gerald I Shulman; Barbara B Kahn
Journal:  J Biol Chem       Date:  2002-07-02       Impact factor: 5.157

9.  Fiber type-specific determinants of Vmax for insulin-stimulated muscle glucose uptake in vivo.

Authors:  Hilary Ann Petersen; Patrick T Fueger; Deanna P Bracy; David H Wasserman; Amy E Halseth
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-03       Impact factor: 4.310

10.  Alterations of nPKC distribution, but normal Akt/PKB activation in denervated rat soleus muscle.

Authors:  Yenshou Lin; Matthew J Brady; Kristen Wolanske; Richard Holbert; Neil B Ruderman; Gordon C Yaney
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-08       Impact factor: 4.310

View more
  23 in total

1.  Insulin resistance in striated muscle-specific integrin receptor beta1-deficient mice.

Authors:  Haihong Zong; Claire C Bastie; Jun Xu; Reinhard Fassler; Kevin P Campbell; Irwin J Kurland; Jeffrey E Pessin
Journal:  J Biol Chem       Date:  2008-12-08       Impact factor: 5.157

Review 2.  Glycogen and its metabolism: some new developments and old themes.

Authors:  Peter J Roach; Anna A Depaoli-Roach; Thomas D Hurley; Vincent S Tagliabracci
Journal:  Biochem J       Date:  2012-02-01       Impact factor: 3.857

3.  Antioxidant effect of myricitrin on hyperglycemia-induced oxidative stress in C2C12 cell.

Authors:  Akram Ahangarpour; Ali Akbar Oroojan; Layasadat Khorsandi; Maryam Kouchak; Mohammad Badavi
Journal:  Cell Stress Chaperones       Date:  2018-03-07       Impact factor: 3.667

4.  Gestational Protein Restriction Impairs Glucose Disposal in the Gastrocnemius Muscles of Female Rats.

Authors:  Chellakkan S Blesson; Vijayakumar Chinnathambi; Sathish Kumar; Chandrasekhar Yallampalli
Journal:  Endocrinology       Date:  2017-04-01       Impact factor: 4.736

5.  Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity.

Authors:  Anil Kumar; Thurl E Harris; Susanna R Keller; Kin M Choi; Mark A Magnuson; John C Lawrence
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

6.  Decreased basal non-insulin-stimulated glucose uptake by diaphragm in streptozotocin-induced diabetic mice infected with Schistosoma mansoni.

Authors:  Hala S Thabet; Nermine K M Saleh; Sahar S Thabet; M Abdel-Aziz; Nagwa K Kalleny
Journal:  Parasitol Res       Date:  2008-05-29       Impact factor: 2.289

7.  Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition.

Authors:  Yun Wang; Moises Torres-Gonzalez; Sasmita Tripathy; Daniela Botolin; Barbara Christian; Donald B Jump
Journal:  J Lipid Res       Date:  2008-03-30       Impact factor: 5.922

Review 8.  Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis.

Authors:  Anthony J Cura; Anthony Carruthers
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

9.  Mice deficient in ribosomal protein S6 phosphorylation suffer from muscle weakness that reflects a growth defect and energy deficit.

Authors:  Igor Ruvinsky; Maximiliano Katz; Avigail Dreazen; Yuval Gielchinsky; Ann Saada; Nanette Freedman; Eyal Mishani; Gabriel Zimmerman; Judith Kasir; Oded Meyuhas
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240

10.  Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77.

Authors:  Lily C Chao; Kevin Wroblewski; Zidong Zhang; Liming Pei; Laurent Vergnes; Olga R Ilkayeva; Shi Ying Ding; Karen Reue; Matthew J Watt; Christopher B Newgard; Paul F Pilch; Andrea L Hevener; Peter Tontonoz
Journal:  Diabetes       Date:  2009-09-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.